Clear Program Physician Webpage
Information specifically for physicians to help your patient understand PAD. Learn More »
Chronic Limb-Threatening Ischemia (CLTI) is a severe form of peripheral artery disease (PAD) that can lead to amputation and increased mortality/cardiovascular events.1 Now, Abbott's Esprit™ BTK System offers a breakthrough innovation for you and your patients as the first-and-only FDA-approved drug-eluting resorbable scaffold for CLTI. With reduced restenosis and reinterventions,3,6,7 and significant improvement in primary patency and limb salvage,3,6 you can be confident you're giving your patients the state-of-the-art standard of care.
Watch how the Esprit™ BTK System does it all for CLTI: addressing vessel recoil and dissection,4 combined with a drug to inhibit neointimal hyperplasia,5 and then fully resorbs over time,9 preserving future treatment options.
Physicians share their experience with the Esprit™ BTK System and the advantages it delivers in treating their patients and improving outcomes.
Beyond the treatment, make sure your referring physicians are fully aware of PAD and CLTI and how they can help with early diagnosis and timely treatment. For information specifically for the physician, visit our Clear Program webpage. Access a full range of helpful tools and insights.
Diameter | 18 | 28 | 38 | Sheath (F)1 | Maximum Post-Dilation Diameter1 | Nominal/RBP Inflation Pressure4 |
---|---|---|---|---|---|---|
2.5 mm | 1203250-18 | 1203250-28 | 1203250-38 | 5F (0.070"/1.8 mm) | 3.0 mm | 9/16 ATM |
3.0 mm | 1203300-18 | 1203300-28 | 1203300-38 | 5F (0.070"/1.8 mm) | 3.5 mm | 9/16 ATM |
3.5 mm | 1203350-18 | 1203350-28 | 1203350-38 | 5F (0.070"/1.8 mm) | 4.0 mm | 9/16 ATM |
3.75 mm | 1203375-18 | 1203375-28 | 1203375-38 | 5F (0.070"/1.8 mm) | 4.25 mm | 9/16 ATM |
This device is commercially available for use in select international markets. Check the regulatory status in your geography.
MAT-2405960 v5.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0